Year: 2011
Type: review
Abstract: Multiple studies have demon-strated that elevated levels ofhigh-sensitivity C-reactive protein (hs-CRP) are associated with increased cardiovascular (CV) risk. Newer CV risk stratification strategies incorporating hs-CRP (e.g., Reynolds Risk Score) have also been shown to improve risk stratifica-tion better than algorithms incorporating only traditional risk factors. There is also evidence from several landmark statin trials that on-treatment hs-CRP levels predict the likelihood of CV events. Al-though there is increasing evidence that CRP may be directly involved in the pathogenesis of atherosclerosis, the ques-tion of whether reduction in CRP levels
Source: Diabetes Care
DOI: 10.2337/dc11-s211
Authors: Jisun Oh, Hwee Teoh, Lawrence A. Leiter
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2144600875
